Glycated Hemoglobin Testing Market Growing at 10.5% CAGR, Expected to Reach $5.16 Billion by 2033, Reports Strategic Revenue Insights

London, UK - November 2025 | Strategic Revenue Insights Inc. - The global Glycated Hemoglobin Testing market is set for rapid expansion, according to the firm's latest report. The sector is projected to grow from $2.10 billion in 2024 to $5.16 billion by 2033, representing a compound annual growth rate (CAGR) of 10.5%. This surge reflects accelerating demand for accurate diabetes diagnostics and long-term glucose monitoring.

Over the forecast period, the market will more than double in size a transformation underpinned by rising prevalence of diabetes and growing awareness about the importance of regular monitoring of blood sugar levels. As the global burden of diabetes increases, healthcare providers and patients alike are leaning heavily on glycated hemoglobin testing to gauge average glucose levels over preceding months, thereby enabling better disease management and reducing complications. Technological advances including more accessible point-of-care (POC) devices and improved testing kits are making HbA1c testing more convenient and widespread, especially in outpatient clinics and remote settings.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Glycated Hemoglobin Testing:

https://www.strategicrevenueinsights.com/industry/glycated-hemoglobin-testing-market

The market's growth is driven by several converging factors. The global rise in diabetes incidence, driven by shifting lifestyles, aging populations, and urbanization, continues to swell the demand for effective diagnostic and monitoring tools. Meanwhile, improvements in diagnostic technology from immunoassay-based kits to chromatography and other advanced methods have made tests more accurate, faster, and easier to deploy. The rise of point-of-care analyzers, which deliver quick and reliable HbA1c results outside major hospitals, is expanding access to diabetes management across both developed and emerging markets.

Also, increasing investments in healthcare infrastructure especially in emerging economies and growing initiatives to improve chronic disease management are creating a supportive environment for market growth.

Regional dynamics are shaping how demand for glycated hemoglobin testing evolves globally. According to the report, the United States remains a leading market, with well-developed healthcare infrastructure, high awareness of diabetes care and widespread screening practices driving substantial demand for HbA1c tests. Meanwhile, Asia-Pacific including markets such as China and India is emerging as a high-growth region. In China, expanding healthcare investment and rising diabetes prevalence are driving strong uptake; in India, growing awareness and greater access to diagnostic services push demand even faster.

In Europe and other developed regions, established diagnostic service networks, combined with growing focus on preventive care and chronic disease management, are sustaining stable demand for glycated hemoglobin testing.
Market segmentation offers further insight into how the Glycated Hemoglobin Testing market is structured. On the component side, instruments, reagents, and kits together form the backbone of the industry with instruments (both lab-based analyzers and POC devices) capturing a major share due to demand for high-throughput testing in hospitals and laboratories.

In terms of application, diabetes diagnosis and diabetes monitoring represent the largest and fastest-growing segments respectively, reflecting increasing need for both first-time detection and ongoing glycemic management. End-users of testing services include hospitals, diagnostic laboratories, research institutes, and specialized diabetes clinics among these, hospitals remain the dominant consumer segment given their scale and capacity to process large volumes of tests.

Browse the associated report:

https://www.strategicrevenueinsights.com/ja/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/kr/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/da/industry/glycated-hemoglobin-testing-market

Several major companies have established strong positions in this market, combining broad portfolios, global distribution networks and R&D capabilities. Firms like Roche Diagnostics and Bio-Rad Laboratories are cited among the key players supplying HbA1c instruments and reagents. Others such as Abbott Laboratories, Siemens Healthiness, Beckman Coulter, and regional diagnostic firms also contribute to market diversity and competition.

Looking ahead to 2033, the Glycated Hemoglobin Testing market appears primed for continued expansion. The growing global prevalence of diabetes driven by demographic, lifestyle and epidemiological shifts will sustain baseline demand for both diagnostic and monitoring services. The shift toward point-of-care testing devices will further expand reach into underserved regions and outpatient settings, broadening the market beyond traditional hospital labs. Technological innovation including smarter, faster, and lower-cost testing solutions should lower barriers to adoption.

Rising public and private investments in healthcare infrastructure, combined with growing awareness of preventive care and chronic disease management, make this a fertile market for manufacturers, diagnostic service providers, and investors alike.

Strategic Revenue Insights believes that stakeholders from diagnostic equipment manufacturers to hospital chains, research labs, and public health bodies who align strategies now around scalable, cost-effective HbA1c solutions stand to benefit from robust growth over the next decade.

Related Reports:

https://www.strategicrevenueinsights.com/industry/hemoglobin-testing-market

Media Contact

Company Name: Strategic Revenue Insights Inc.

Contact Person: Ashwani

Email: sales@strategicrevenueinsights.com

Phone: +44 7877 403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

Country: United Kingdom

Website: www.strategicrevenueinsights.com

Website: www.strategicpackaginginsights.com

About Strategic Revenue Insights Inc.
Strategic Revenue Insights Inc., a subsidiary of SRI Consulting Group Ltd, empowers organizations worldwide with data-driven market intelligence. Headquartered in London, United Kingdom, the firm delivers syndicated research reports, tailored consulting solutions, and actionable insights that equip clients to make confident, future-focused strategic decisions. Its team of seasoned analysts continuously tracks markets, identifies emerging trends, and uncovers growth opportunities to support long-term client success. As part of SRI Consulting Group Ltd, Strategic Revenue Insights Inc. is committed to accuracy, clarity, and practical relevance, helping businesses optimize strategies and accelerate revenue growth.

This release was published on openPR.